Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Open J Immunol. 2017 Mar 29;7(1):1–17. doi: 10.4236/oji.2017.71001

Figure 4.

Figure 4

Presence of soluble MICB in plasma and urine from juvenile-onset SLE patients. (a) Overall data point distribution and statistical evaluation (y = 10 ^ [−1.9 + 1.2 * log(x)], R-squared = 0.3; p = 0.009) of soluble MICB plasma concentrations (ng/ml; log scale) in relationship to frequencies of NKG2D+CD4 T cells in the 22 jSLE patient samples studied. (b) Comparisons of soluble MICB plasma concentrations (ng/ml; log scale) in jSLE patients with active disease to those of patients with inactive disease. Horizontal lines and error bars show median and interquartile range. (c) Tabulation of soluble MICA and soluble MICB concentrations (pg/ml) in urine and paired plasma from five jSLE patients. Patient ID = jSLE patient identification.